Multi-biomarker Risk Score Predicts Complex Revascularizatio

The findings provide insight into the relationship between cardiovascular biomarkers, coronary anatomical complexity, and incident clinical events.

Related Keywords

Boston , Massachusetts , United States , Paris , France General , France , Coll Cardiol , Brian Bergmark , Giles Montalescot , Zora Biosciences , Amgen , Boehringer Ingelheim , Novartis , Pfizer , Astrazeneca , Journal Of The American College Cardiology , Bayer Healthcare Pharmaceuticals , Bristol Myers Squibb , Quark Pharmaceuticals , Regeneron Pharmaceuticals , Medicines Company , Study Group , Boston Scientific , Harvard Medical School , Philips , Medtronic , American College , Anthos Therapeutics , Siemens Healthcare Diagnostics , Abbott Vascular , Quantum Genomics , Cv , Ardiovascular , Biomarker , Iological Marker , Acute Coronary Syndrome Acs , Cute Coronary Syndrome , Cs , Atherosclerotic Heart Disease , Therosclerotic Cardiovascular Disease , Oronary Heart Disease , Schemic Heart Disease , Coronary Atherosclerosis , Lipids , Ipid Management , Heart Failure , , Hypertension , Myocardial Infarction , Revascularization Procedures In Coronary Artery Disease , Revascularization ,